Chargement en cours...
Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation
Rivaroxaban is a direct oral anticoagulant (DOAC) approved for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation, a common arrhythmia. In this review, we summarize the effectiveness of rivaroxaban versus warfarin and the DOACs dabigatran, apixaban and ed...
Enregistré dans:
| Publié dans: | J Comp Eff Res |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Future Medicine Ltd
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5827778/ https://ncbi.nlm.nih.gov/pubmed/28737102 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cer-2017-0025 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|